# Haemonetics Corp: Form 8-K, filed May 1, 2024

- Company: [Haemonetics Corp](/companies/hae.md) (CIK 313143)
- Form: 8-K
- Filed: 2024-05-01
- Accepted by EDGAR: May 1, 2024, 20:12 ET
- Period: 2024-04-30
- Accession: 0000950103-24-006128
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313143/000095010324006128/dp210533_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313143/000095010324006128/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/313143/000095010324006128/dp210533_8k.htm

Filed May 1, 2024.
Source: SEC EDGAR, the filing index for accession 0000950103-24-006128. Last ingested by Listed: Oct 24, 2026, 14:55 ET. No prices; not investment advice.